Printer Friendly

Collegium introduces OpioidIQ on website.

M2 EQUITYBITES-September 6, 2016-Collegium introduces OpioidIQ on website


Pharmaceutical company Collegium Pharmaceutical (NasdaqGS:COLL) stated on Tuesday that it has introduced its online educational tool OpioidIQ at

The company said the online OpioidIQ will assist physicians and healthcare providers with effective pain management. It will connect healthcare providers to information and resources aimed at supporting the safe and effective management of their patients with chronic pain who are appropriate for treatment with an opioid analgesic.

In addition, OpioidIQ provides physicians and other allied healthcare providers with tools to assess which patients are appropriate for opioid analgesics and important topics that need to be addressed with patients when deciding to treat them with an opioid analgesic.

According to the company, the important topics that need to be addressed include appropriate opioid use, risks of unintentional misuse and abuse,enhancing communications between patients and healthcare providers, resources for providing information to patients and caregivers to avoid unintentional opioid misuse as well as role of abuse-deterrent formulations (ADFs).

((Comments on this story may be sent to

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Sep 6, 2016
Previous Article:D R Horton announces acquisition of Wilson Parker Homes' home building operations for about USD90m cash.
Next Article:Zynerba Pharmaceuticals begins Phase 2 clinical trial of ZYN002 CBD Gel for osteoarthritis.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters